Giessen Pulmonary Hypertension Registry and Biobank

University of Giessen10,000 enrolled

Overview

Long-term transplant-free survival and its determinants will be investigated in patients with Pulmonary Hypertension (diagnosed by right heart catheterization) within a prospective registry at a single referral center in Giessen, Germany.

Study Type

OBSERVATIONAL

Enrollment

10,000

Conditions

Pulmonary Hypertension

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Right heart catheterization for PH diagnosis in Giessen Exclusion Criteria: * informed consent missing

Locations (1)

Department of Intermal Medicine - Universities of Giessen and Marburg Lung Center

Giessen, Germany

RECRUITING

Outcomes

Primary Outcomes

Survival

Transplant-free survival of PH patients

Time frame: Up to 20 years after enrollment

Central Contacts

Khodr Tello, MD

CONTACT

0641/985-51250 khodr.tello@innere.med.uni-giessen.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.